Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate versus etomidate for sedation during induction of TAVI
ChiCTR2200056842Phase 4Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in aortic stenosis (AS) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Bispectral index (BIS), Mean arterial pressure and 4 more. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on ChiCTR2200056842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056842.